Ranking | Company (Ticker) | Year-to-Date Performance
1 HeartWare International, Inc. (NASDAQ:HTWR) 8721.6%
2 Vasogen Inc. (USA) (NASDAQ:IPCI) 2344.3%
3 Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) 1956.0%
4 Human Genome Sciences (NASDAQ:HGSI) 1191.5%
5 Opexa Therapeutics Inc. (NASDAQ:OPXA) 979.0%
Biotech stocks discussed include PFE, GLD, MRK, PFE.
Rosanne Ott, portfolio manager for the four star Alger Health Sciences Fund, says health care stocks will benefit during President Obama’s first 100 days in office, especially generic drug-makers Teva and Mylan.
Recent Comments